Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
49.45
-5.35 (-9.76%)
At close: Mar 27, 2026

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Western Medicine and Class B Patent Medicines
130.70M117.87M
Western Medicine and Class B Patent Medicines Growth
10.89%-
Total
130.70M117.87M
Total Growth
10.89%-

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Taiwan
130.70M117.87M
Taiwan Growth
10.89%-
Total
130.70M117.87M
Total Growth
10.89%-
Source: S&P Global Market Intelligence.